aboratory evaluation of ß-hydroxybutyrate levels in capillary and venous blood

Not Applicable

• Conditions: Diabetic ketoacidosis or ketosis; Nutritional, Metabolic, Endocrine; Diabetes mellitus with ketosis

• Registration Number: ISRCTN31042751
• Lead Sponsor: Abbott (United Kingdom)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-12-20
• Last Update Posted: 7 September 2020
• Study Completion: 2020-09-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

1. Aged 16 years or over
2. Potentially ketotic, or in diabetic ketoacidosis

Exclusion Criteria

1. Already participated in this study
2. Concomitant medical condition which in the investigator’s opinion could interfere with the study or present a risk to the safety or welfare of the participant or study staff
3. Infected with hepatitis B virus (Hep B), hepatitis C virus (Hep C), or human immunodeficiency virus (HIV)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Capillary blood ß-hydroxybutyrate levels and venous blood ß-hydroxybutyrate levels as measured on the Randox Ranbut laboratory reference method using Bland-Altman analysis at each visit